Furthermore, increases in haematocrit and uric acid-lowering effects were observed, which is relevant because these biochemical alterations are closely linked statistically as mediators of clinical benefits of SGLT2i in kidney and cardiovascular outcome trials [40, 41]
B.et al
Cross-talk between cardiac muscle and coronary vasculature
Adiponectin levels and sleep deprivation in patients with endocrine metabolic disorders
In 2014, Saxenda was the first GLP-1 introduced specifically for chronic weight management, followed by Wegovy in 2021 and Zepbound in 2023
Disclosures: Jieun Kim: Nothing to Disclose, So Yeon Kim: Nothing to Disclose, Jina Kim: Nothing to Disclose, Alexander Xu: Nothing to Disclose, Sungyong You: Nothing to Disclose, Ekihiro Seki: Nippon Zoki: Research Grant Support, Novonordisc: Consultant 711 CURRENT BURDEN AND GEOGRAPHIC DISPARITIES IN LIVER MORTALITY AND ACCESS TO LIVER TRANSPLANTATION Nicolas Rinella 1 William Charlton 2 Paige McLean Diaz 3 K